Imunon, Inc. (IMNN) Insider Trading
Directors, officers and holders of more than 10% of IMNN report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 102 transactions on file: 0 with code P, 6 with code S and 44 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 23, 2026 | Lindborg Stacy | President and CEO | A Award | 2,603 | $1.24 | $3,215 |
| Oct 23, 2026 | Tardugno Michael H | Executive Chairman of Board | A Award | 6,821 | $1.24 | $8,424 |
| Oct 23, 2026 | Faller Douglas Vincent | Chief Medical Officer | A Award | 1,092 | $1.24 | $1,349 |
| Oct 23, 2026 | Faller Douglas Vincent | Chief Medical Officer | A Award | 26,741 | $1.24 | $33,025 |
| Oct 9, 2026 | Tardugno Michael H | Executive Chairman of Board | A Award | 7,800 | $1.08 | $8,424 |
| Oct 9, 2026 | Lindborg Stacy | President and CEO | A Award | 2,977 | $1.08 | $3,215 |
| Oct 9, 2026 | Faller Douglas Vincent | Chief Medical Officer | A Award | 1,249 | $1.08 | $1,349 |
| Sep 25, 2026 | Faller Douglas Vincent | Chief Medical Officer | A Award | 4,390 | $1.41 | $6,190 |
| Sep 25, 2026 | Lindborg Stacy | President and CEO | A Award | 6,697 | $1.41 | $9,443 |
| Sep 25, 2026 | Tardugno Michael H | Executive Chairman of Board | A Award | 7,169 | $1.41 | $10,108 |
| Sep 11, 2026 | Faller Douglas Vincent | Chief Medical Officer | A Award | 4,211 | $1.47 | $6,190 |
| Sep 11, 2026 | Tardugno Michael H | Executive Chairman of Board | A Award | 5,824 | $1.47 | $8,561 |
| Sep 11, 2026 | Lindborg Stacy | President and CEO | A Award | 5,504 | $1.47 | $8,091 |
| Aug 31, 2026 | Eylward Susan | General Counsel and Corp Sec | S Sale | 2,525 | $1.56 | $3,950 |
| Aug 28, 2026 | Eylward Susan | General Counsel and Corp Sec | A Award | 2,525 | $1.60 | $4,040 |
| Aug 28, 2026 | Lindborg Stacy | President and CEO | A Award | 6,822 | $1.60 | $10,915 |
| Aug 28, 2026 | Tardugno Michael H | Executive Chairman of Board | A Award | 7,371 | $1.60 | $11,794 |
| Aug 28, 2026 | Faller Douglas Vincent | Chief Medical Officer | A Award | 3,626 | $1.60 | $5,802 |
| Aug 17, 2026 | Eylward Susan | General Counsel and Corp Sec | S Sale | 2,449 | $1.63 | $3,993 |
| Aug 14, 2026 | Lindborg Stacy | President and CEO | A Award | 6,615 | $1.65 | $10,915 |
| Aug 14, 2026 | Eylward Susan | General Counsel and Corp Sec | A Award | 2,449 | $1.65 | $4,041 |
| Aug 14, 2026 | Tardugno Michael H | Executive Chairman of Board | A Award | 7,147 | $1.65 | $11,793 |
| Aug 14, 2026 | Faller Douglas Vincent | Chief Medical Officer | A Award | 3,516 | $1.65 | $5,801 |
| Aug 3, 2026 | Eylward Susan | General Counsel and Corp Sec | S Sale | 2,541 | $1.57 | $3,977 |
| Jul 31, 2026 | Lindborg Stacy | President and CEO | A Award | 5,010 | $1.59 | $7,966 |
| Jul 31, 2026 | Faller Douglas Vincent | Chief Medical Officer | A Award | 3,649 | $1.59 | $5,802 |
| Jul 31, 2026 | Tardugno Michael H | Executive Chairman of Board | A Award | 6,358 | $1.59 | $10,109 |
| Jul 31, 2026 | Braun Donald P | Director | A Award | 6,180 | $1.59 | $9,826 |
| Jul 31, 2026 | Eylward Susan | General Counsel and Corp Sec | A Award | 2,541 | $1.59 | $4,040 |
| Jul 31, 2026 | Fritz Frederick J. | Director | A Award | 6,934 | $1.59 | $11,025 |
| Jul 31, 2026 | Dentzer James E | Director | A Award | 6,934 | $1.59 | $11,025 |
| Jul 31, 2026 | Pellizzari Christine A | Director | A Award | 6,934 | $1.59 | $11,025 |
| Jul 20, 2026 | Eylward Susan | General Counsel and Corp Sec | S Sale | 2,150 | $1.78 | $3,830 |
| Jul 17, 2026 | Eylward Susan | General Counsel and Corp Sec | A Award | 2,150 | $1.83 | $3,935 |
| Jul 17, 2026 | Tardugno Michael H | Executive Chairman of Board | A Award | 4,603 | $1.83 | $8,423 |
| Jul 17, 2026 | Lindborg Stacy | President and CEO | A Award | 4,907 | $1.83 | $8,980 |
| Jul 17, 2026 | Faller Douglas Vincent | Chief Medical Officer | A Award | 3,082 | $1.83 | $5,640 |
| Jul 6, 2026 | Eylward Susan | General Counsel and Corp Sec | S Sale | 920 | $1.88 | $1,730 |
| Jul 2, 2026 | Lindborg Stacy | President and CEO | A Award | 2,534 | $1.91 | $4,840 |
| Jul 2, 2026 | Faller Douglas Vincent | Chief Medical Officer | A Award | 1,308 | $1.91 | $2,498 |
| Jul 2, 2026 | Eylward Susan | General Counsel and Corp Sec | A Award | 920 | $1.91 | $1,757 |
| Jul 2, 2026 | Tardugno Michael H | Executive Chairman of Board | A Award | 4,410 | $1.91 | $8,423 |
| Jun 29, 2026 | Eylward Susan | General Counsel and Corp Sec | S Sale | 11,800 | $1.75 | $20,674 |
| Jun 25, 2026 | Lindborg Stacy | President and CEO | A Award | 67,150 | $1.72 | $115,498 |
| Jun 25, 2026 | Tardugno Michael H | Executive Chairman of Board | A Award | 42,519 | $1.72 | $73,133 |
| Jun 25, 2026 | Eylward Susan | General Counsel and Corp Sec | A Award | 14,696 | $1.72 | $25,277 |
| Jun 25, 2026 | Faller Douglas Vincent | Chief Medical Officer | A Award | 21,896 | $1.72 | $37,661 |
| Jun 18, 2026 | Lindborg Stacy | President and CEO | A Award | 1,803 | $1.82 | $3,281 |
| Jun 18, 2026 | Tardugno Michael H | Executive Chairman of Board | A Award | 4,629 | $1.82 | $8,425 |
| Jun 5, 2026 | Tardugno Michael H | Executive Chairman of Board | A Award | 4,089 | $2.06 | $8,423 |
The full Form 4 history is on the IMNN company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.